ID Name Structure References (top 5) Molecular Target(s)
1ID:8004
(TRANS)-BETA-FARNESENE

Freqency:
in 2 ingredients:

  • 5
  • 645
  • in 8 recipes:

  • 8
  • 10
  • 107
  • 212
  • 215
  • 259
  • 308
  • 351

  • Properties
    C15H24    204.35





    1:  Abramovitch RB, Kim YJ, Chen S, Dickman MB, Martin GB.
    Pseudomonas type III effector AvrPtoB induces plant disease susceptibility by inhibition of host programmed cell death.
    EMBO J.    impact factor:   13.973
    2003;  22(1): 60-9

    2:  Mattera R, Arighi CN, Lodge R, Zerial M, Bonifacino JS.
    Divalent interaction of the GGAs with the Rabaptin-5-Rabex-5 complex.
    EMBO J.    impact factor:   13.973
    2003;  22(1): 78-88

    3:  Prevot V, Rio C, Cho GJ, Lomniczi A, Heger S, Neville CM, Rosenthal NA, Ojeda SR, Corfas G.
    Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes.
    J Neurosci.    impact factor:   8.955
    2003;  23(1): 230-9

    4:  Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S, Glodek A, Honczarenko M, Spruce LA, Janowska-Wieczorek A, Lambris JD, Ratajczak MZ.
    Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1.
    Blood.    impact factor:   8.782
    2003;   [e-pub ahead of print]

    5:  Sohal J, Phan VT, Chan PV, Davis EM, Patel B, Kelly LM, Abrams TJ, O'Farrell AM, Gilliland DG, Le Beau MM, Kogan SC.
    A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.
    Blood.    impact factor:   8.782
    2002;   [e-pub ahead of print]

     
    Time used: 125 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005